Covered recipient · General Payments record
DIANA KERWIN
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2018–2024
$78,994.08
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,530.00 | 6 |
| Travel and Lodging | $1,028.78 | 3 |
| Food and Beverage | $503.64 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $7,878.63 | 3 |
| EISAI INC. | $6,065.36 | 11 |
| Novo Nordisk AS | $2,931.50 | 2 |
| E.R. Squibb & Sons, L.L.C. | $116.23 | 1 |
| F. Hoffmann-La Roche AG | $70.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $116.23 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101357424 | CMS |
| Eisai Inc. | $1,880.00 | 01/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110741859 | CMS |
| Eisai Inc. | $2,585.00 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110741861 | CMS |
| Eisai Inc. | $118.01 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741865 | CMS |
| Eisai Inc. | $139.48 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110741869 | CMS |
| Eisai Inc. | $210.67 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110741873 | CMS |
| Eisai Inc. | $43.69 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741867 | CMS |
| Eisai Inc. | $22.95 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741871 | CMS |
| Eisai Inc. | $49.28 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741875 | CMS |
| Eisai Inc. | $24.30 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741877 | CMS |
| Eisai Inc. | $51.98 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741879 | CMS |
| Eisai Inc. | $940.00 | 10/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110741863 | CMS |
| F. Hoffmann-La Roche AG | $70.70 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133001701 | CMS |
| Lilly USA, LLC | $678.63 | 11/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1136169405 | CMS |
| Lilly USA, LLC | $5,625.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136138493 | CMS |
| Lilly USA, LLC | $1,575.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136157763 | CMS |
| Novo Nordisk Inc | $2,925.00 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097693130 | CMS |
| Novo Nordisk Inc | $6.50 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097781396 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.